Literature DB >> 30951701

Visualization and quantification of NK cell-mediated cytotoxicity over extended time periods by image cytometry.

Leo Li-Ying Chan1, Kai W Wucherpfennig2, Lucas Ferrari de Andrade2.   

Abstract

Natural killer (NK) cell-mediated cytotoxicity is traditionally measured using the chromium release assay, which measures the fraction of radioactive 51Cr released from dying target cells co-cultured with NK cells. However, the time frame of 51Cr release assays is limited to approximately 4 h due to spontaneous release of 51Cr. In the tumor microenvironment, interactions between NK cells and tumor cells occur over extended time periods, and NK cell-mediated cytotoxicity is modulated by cytokines produced by tumor cells and other immune cells. Here we demonstrate that the interaction of NK cells and tumor cells can be imaged and quantified over an extended period of time using a novel image cytometry method. Specifically, we imaged killing of human ZsGreen+ melanoma cells by primary human NK cells in the presence of an antibody targeting MICA and MICB on the tumor cell surface. The number of live ZsGreen+ A375 cells was counted in 96-well plates over a three day time frame, and the results were used to first calculate % specific killing at the 4 h time point to compare to 51Cr release assay. Analysis of data from the 4 h time point demonstrated that both 51Cr and image cytometry enable sensitive detection of NK cell-mediated killing of tumor cells. Image cytometry demonstrated that the combination of the MICA/B antibody and IL-2 induced near-complete eradication of A375 melanoma cells by NK cells at later time points. This novel image cytometry based approach will be suitable for the discovery of combination therapies that enhance the cytotoxic function of NK cells against tumor cells.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody-dependent cell-mediated cytotoxicity (ADCC); Celigo; Chromium release assay; Image cytometry; Natural killer (NK) cell

Mesh:

Substances:

Year:  2019        PMID: 30951701     DOI: 10.1016/j.jim.2019.04.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Combined analysis of T cell activation and T cell-mediated cytotoxicity by imaging cytometry.

Authors:  Monica K Chanda; Claire E Shudde; Taylor L Piper; Yating Zheng; Adam H Courtney
Journal:  J Immunol Methods       Date:  2022-05-27       Impact factor: 2.287

2.  Characterization of CAR T cell expansion and cytotoxic potential during Ex Vivo manufacturing using image-based cytometry.

Authors:  Colby R Maldini; Andrea C Love; Kevin W Tosh; Leo Li-Ying Chan; Kevin Gayout; Tim Smith; James L Riley
Journal:  J Immunol Methods       Date:  2020-08-01       Impact factor: 2.303

3.  Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.

Authors:  Lucas Ferrari de Andrade; Sushil Kumar; Adrienne M Luoma; Yoshinaga Ito; Pedro Henrique Alves da Silva; Deng Pan; Jason W Pyrdol; Charles H Yoon; Kai W Wucherpfennig
Journal:  Cancer Immunol Res       Date:  2020-03-24       Impact factor: 11.151

4.  AURKB: a promising biomarker in clear cell renal cell carcinoma.

Authors:  Bangbei Wan; Yuan Huang; Bo Liu; Likui Lu; Cai Lv
Journal:  PeerJ       Date:  2019-09-16       Impact factor: 2.984

5.  Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.

Authors:  Xingying Zhang; Xin Wen; Ning Feng; Aoxing Chen; Senbang Yao; Xin Ding; Longzhen Zhang
Journal:  Med Sci Monit       Date:  2020-06-20

6.  A novel CD2 staining-based flow cytometric assay for assessment of natural killer cell cytotoxicity.

Authors:  Dan Zhang; Rui Teng; Nan Lv; Lei Lei; Yanmeng Wang; Ramone A Williamson; Ping Chen; Peigen Gao; Michael O'Dwyer; Ang Li; Jinsong Hu
Journal:  J Clin Lab Anal       Date:  2020-08-17       Impact factor: 3.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.